The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
TWST.COM Logo
  • Home
  • Experts
  • Reports
  • Products
  • News
  • About Us
  • Series
    • General Investing
    • Financial Services
    • Consumer
    • Industry & Services
    • Natural Resources
    • Healthcare
    • Technology
  • Contact Us

Hibbett Sports, Inc.

Related Interviews

Buy Quality and Wait for the Value to Surface
July 18, 2024
Wutherich, Wil

Interview with the CEO and President: Hibbett Sports, Inc. (NASDAQ:HIBB)
August 07, 2020
Longo, Michael E.

Outlook For Specialty Retail - Christine Chen - Needham & Company, Llc
September 07, 2009

GERALD JORDAN - HELLMAN JORDAN MANAGEMENT COMPANY INC
April 24, 2006

INVESTING IN REITs: ANTHONY PAOLONE - J.P. MORGAN SECURITIES
April 25, 2005

BUSINESS & INFORMATION SERVICES: WILLIAM WARMINGTON - SUNTRUST ROBINSON HUMPHREY CAPITAL MARKETS
May 25, 2004

David Bupp - Neoprobe Corporation (neop)
May 03, 2004

PHILLIP BLUNDELL - INTELLIGENT ENVIRONMENTS GROUP PLC (IEN.L)
March 01, 2004

Venture Investing In Biotechnology: G.steven Burrill - Burrill & Co
January 27, 2003

Home Improvement & Home Furnishing Stores: Ozarslan Tangun - Sws Securities
August 19, 2002

Louis Lange - Cv Therapeutics Inc (cvtx)
October 12, 2001

Eric Schiffer - 99 Cents Only Stores (ndn)
September 25, 2001

Apparel Retailing: Dennis Van Zelfden - Robinson Humphrey Company Llc
April 09, 2001

Ian Harley - Abbey National (anl.l)
October 04, 1999

Mark B. Templeton - Citrix Systems Inc (ctxs)
December 21, 1998

Cart

Latest News

The Robots from this Company Will Build You a New Spine
Lord Abbett Portfolio Manager Reveals the Process for Picking Winning Innovative Growth Stocks
Fundamental Analysis on Small Cap Stocks: Value Upside Returns

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

Subscribe now!

Sign Up For Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews

Interview with the CEO: Niagen Bioscience Inc. (NASDAQ:NAGE)

Robert Fried

Published March 02, 2026 in Biotechnology and Pharmaceuticals

Companies covered: NAGE

Buy ($25)

Interview with the CEO: Vaxart Inc. (OTCMKTS:VXRT)

Steven Lo

Published March 02, 2026 in Biotechnology and Pharmaceuticals

Companies covered: VXRT

Buy ($25)

Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)

Frank Bedu-Addo

Published March 02, 2026 in Biotechnology and Pharmaceuticals

Companies covered: PDSB

Buy ($25)

Most Popular Reports

Biotechnology and Pharmaceuticals

Published March 02, 2026

Topics covered: Biotechnology and Pharmaceuticals

Buy ($175)

Medical Devices and Life Science Tools

Published February 23, 2026

Topics covered: Medical Devices and Life Science Tools

Buy ($175)

Investing Strategies: Micro, Small and Smid Cap

Published February 05, 2026

Topics covered: Micro, Small and Smid Cap

Buy ($175)

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
GE Aerospace (General Electric Company)
Walmart Inc.
IBM (International Business Machines Corp.)
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Niagen Bioscience Inc. (NASDAQ:NAGE)
Interview with the CEO: Vaxart Inc. (OTCMKTS:VXRT)
Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Supply Constraints Translate Into Pricing Power for Eagle Materials
Share Price Pullback Creates Attractive Entry Point for Urban Outfitters
VSE Corp: A Play on Strong Aerospace Aftermarket Demand
ANALYST INTERVIEWS
Argenx Builds Momentum on Strong Execution and Expanding Indications
Omeros Tackles Lethal Transplant Risks with First-in-Class Therapy
Uptick in M&A Among Tailwinds Boosting Biotech Sector
Subscribe Today!
Since 1963
© The Wall Street Transcript 2016, 2026
Terms and Conditions
Privacy Policy
 
 
https://www.twst.com/wp-admin/admin-ajax.php
  • Join now for free!
  • Already a member?

or create an account with a social network.

Join with Facebook
Join with Twitter
Join with Google
Join now! | Forgot password?

or login using a social network


Log in with Facebook
Log in with Twitter
Log in with Google